Organogenesis
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $43,755 | $37,228 | $225,071 | $150,487 |
Gross Profit | 20,082 | -913 | 175,153 | 114,236 |
EBITDA | -47,212 | -56,103 | 70,440 | 28,147 |
EBIT | -50,880 | -68,473 | 63,427 | 21,160 |
Net Income | -99,339 | -56,159 | 43,700 | 21,567 |
Net Change In Cash | 43,755 | 37,228 | 225,071 | 150,487 |
Free Cash Flow | -32,753 | 17,981 | 34,768 | 844 |
Cash | 46,097 | 92,099 | 93,679 | 64,372 |
Basic Shares | 128,674 | 127,797 | 132,206 | 130,848 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $563,030 | $482,043 | $433,140 | $450,893 |
Gross Profit | 425,508 | 366,302 | 326,659 | 345,874 |
EBITDA | 73,908 | 15,763 | 36,031 | 40,322 |
EBIT | 46,970 | -1,263 | 12,582 | 22,291 |
Net Income | 37,032 | 861 | 4,945 | 15,532 |
Net Change In Cash | 563,030 | 482,043 | 433,140 | 450,893 |
Cost of Revenue | -11,238 | |||
Free Cash Flow | -24,460 | 4,176 | 6,553 | -9,039 |
Cash | 93,679 | 135,571 | 104,338 | 102,478 |
Basic Shares | 130,248 | 131,673 | 132,746 | 132,383 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.71 |
2026-03-31 | -$0.34 |
2025-12-31 | $0.31 |
2025-09-30 | $0.18 |